A trial by the Butantan Institute in Brazil reported an efficacy of 50.38% for China’s COVID-19 Vaccine, Sinovac. Prof … read more
A comment from Professor Sheila Bird on the latest NHS COVID-19 vaccination statistics in England, for the week ending Sunday … read more
There have been reports in the US that President elect Joe Biden plans to release nearly all available vaccine doses … read more
A preprint, an unpublished non-peer reviewed study, suggests the Pfizer/BioNTech COVID-19 vaccine might still be effective against the new SARS-CoV-2 … read more
It has been announced today that the European Medicines Agency (EMA) has recommended the COVID-19 vaccine Moderna for authorisation in … read more
Several journalists have asked us about the government’s vaccination timeline, so here are some comments from scientists. Comments sent … read more
Comments from scientists on combining different COVID-19 vaccines in a heterologous prime-boost regimen. Prof Helen Fletcher, Professor of Immunology … read more
Comments from scientists on dose spacing of the COVID-19 vaccines. Prof Sheila Bird, formerly Programme Leader, MRC Biostatistics Unit, … read more
It has been announced this morning that the UK government has accepted the recommendation from the independent Medicines and Healthcare products … read more
Tony Blair has made comments suggesting we should consider using all available vaccine doses in January as first doses, rather … read more
We gave journalists the opportunity to ask the panellists anything they want about vaccines – from specific covid-related details to … read more
The FDA in the USA issued an Emergency Use Authorisation for the Moderna COVID-19 vaccine. Dr Craig Hartford, member … read more
An editorial published in Anaesthesia looks at the global COVID-19 vaccination program. Dr Andrew Garrett, Executive Vice President of … read more
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine, allowing it … read more
AstraZeneca have announced a clinical trial programme to assess safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca … read more
The results of the phase 3 clinical trials of the Pfizer/BioNTech COVID-19 vaccine candidate have been published in NEJM. … read more
Sanofi and GSK have announced a delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme to improve immune response in … read more
There have been news reports of 2 NHS workers having allergic reactions in response to the Pfizer/BioNTech COVID-19 vaccine. … read more
We recently heard the interim high-level results from phase 3 clinical trials of the Oxford AstraZeneca COVID-19 vaccine in the … read more
The results of the phase 3 clinical trials of the Oxford AstraZeneca COVID-19 vaccine candidate have been published in The … read more
